Cargando…

Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is a complex neurodegenerative disease, and genetic differences may mediate neuronal degeneration. In humans, a single-nucleotide polymorphism in the B-cell chronic lymphocytic leukemia/lymphoma-2 (Bcl-2) gene, rs956572, has been found to significantly modulate B...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chiung-Chih, Chang, Ya-Ting, Huang, Chi-Wei, Tsai, Shih-Jen, Hsu, Shih-Wei, Huang, Shu-Hua, Lee, Chen-Chang, Chang, Wen-Neng, Lui, Chun-Chung, Lien, Chia-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806294/
https://www.ncbi.nlm.nih.gov/pubmed/29422088
http://dx.doi.org/10.1186/s13195-018-0344-4
_version_ 1783299099201634304
author Chang, Chiung-Chih
Chang, Ya-Ting
Huang, Chi-Wei
Tsai, Shih-Jen
Hsu, Shih-Wei
Huang, Shu-Hua
Lee, Chen-Chang
Chang, Wen-Neng
Lui, Chun-Chung
Lien, Chia-Yi
author_facet Chang, Chiung-Chih
Chang, Ya-Ting
Huang, Chi-Wei
Tsai, Shih-Jen
Hsu, Shih-Wei
Huang, Shu-Hua
Lee, Chen-Chang
Chang, Wen-Neng
Lui, Chun-Chung
Lien, Chia-Yi
author_sort Chang, Chiung-Chih
collection PubMed
description BACKGROUND: Alzheimer’s disease (AD) is a complex neurodegenerative disease, and genetic differences may mediate neuronal degeneration. In humans, a single-nucleotide polymorphism in the B-cell chronic lymphocytic leukemia/lymphoma-2 (Bcl-2) gene, rs956572, has been found to significantly modulate Bcl-2 protein expression in the brain. The Bcl-2 AA genotype has been associated with reduced Bcl-2 levels and lower gray matter volume in healthy populations. We hypothesized that different Bcl-2 genotype groups may modulate large-scale brain networks that determine neurobehavioral test scores. METHODS: Gray matter structural covariance networks (SCNs) were constructed in 104 patients with AD using T1-weighted magnetic resonance imaging with seed-based correlation analysis. The patients were stratified into two genotype groups on the basis of Bcl-2 expression (G carriers, n = 76; A homozygotes, n = 28). Four SCNs characteristic of AD were constructed from seeds in the default mode network, salience network, and executive control network, and cognitive test scores served as the major outcome factor. RESULTS: For the G carriers, influences of the SCNs were observed mostly in the default mode network, of which the peak clusters anchored by the posterior cingulate cortex seed determined the cognitive test scores. In contrast, genetic influences in the A homozygotes were found mainly in the executive control network, and both the dorsolateral prefrontal cortex seed and the interconnected peak clusters were correlated with the clinical scores. Despite a small number of cases, the A homozygotes showed greater covariance strength than the G carriers among all four SCNs. CONCLUSIONS: Our results suggest that the Bcl-2 rs956572 polymorphism is associated with different strengths of structural covariance in AD that determine clinical outcomes. The greater covariance strength in the four SCNs shown in the A homozygotes suggests that different Bcl-2 polymorphisms play different modulatory roles. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0344-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5806294
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58062942018-02-15 Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease Chang, Chiung-Chih Chang, Ya-Ting Huang, Chi-Wei Tsai, Shih-Jen Hsu, Shih-Wei Huang, Shu-Hua Lee, Chen-Chang Chang, Wen-Neng Lui, Chun-Chung Lien, Chia-Yi Alzheimers Res Ther Research BACKGROUND: Alzheimer’s disease (AD) is a complex neurodegenerative disease, and genetic differences may mediate neuronal degeneration. In humans, a single-nucleotide polymorphism in the B-cell chronic lymphocytic leukemia/lymphoma-2 (Bcl-2) gene, rs956572, has been found to significantly modulate Bcl-2 protein expression in the brain. The Bcl-2 AA genotype has been associated with reduced Bcl-2 levels and lower gray matter volume in healthy populations. We hypothesized that different Bcl-2 genotype groups may modulate large-scale brain networks that determine neurobehavioral test scores. METHODS: Gray matter structural covariance networks (SCNs) were constructed in 104 patients with AD using T1-weighted magnetic resonance imaging with seed-based correlation analysis. The patients were stratified into two genotype groups on the basis of Bcl-2 expression (G carriers, n = 76; A homozygotes, n = 28). Four SCNs characteristic of AD were constructed from seeds in the default mode network, salience network, and executive control network, and cognitive test scores served as the major outcome factor. RESULTS: For the G carriers, influences of the SCNs were observed mostly in the default mode network, of which the peak clusters anchored by the posterior cingulate cortex seed determined the cognitive test scores. In contrast, genetic influences in the A homozygotes were found mainly in the executive control network, and both the dorsolateral prefrontal cortex seed and the interconnected peak clusters were correlated with the clinical scores. Despite a small number of cases, the A homozygotes showed greater covariance strength than the G carriers among all four SCNs. CONCLUSIONS: Our results suggest that the Bcl-2 rs956572 polymorphism is associated with different strengths of structural covariance in AD that determine clinical outcomes. The greater covariance strength in the four SCNs shown in the A homozygotes suggests that different Bcl-2 polymorphisms play different modulatory roles. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13195-018-0344-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-08 /pmc/articles/PMC5806294/ /pubmed/29422088 http://dx.doi.org/10.1186/s13195-018-0344-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chang, Chiung-Chih
Chang, Ya-Ting
Huang, Chi-Wei
Tsai, Shih-Jen
Hsu, Shih-Wei
Huang, Shu-Hua
Lee, Chen-Chang
Chang, Wen-Neng
Lui, Chun-Chung
Lien, Chia-Yi
Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
title Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
title_full Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
title_fullStr Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
title_full_unstemmed Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
title_short Associations of Bcl-2 rs956572 genotype groups in the structural covariance network in early-stage Alzheimer’s disease
title_sort associations of bcl-2 rs956572 genotype groups in the structural covariance network in early-stage alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806294/
https://www.ncbi.nlm.nih.gov/pubmed/29422088
http://dx.doi.org/10.1186/s13195-018-0344-4
work_keys_str_mv AT changchiungchih associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT changyating associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT huangchiwei associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT tsaishihjen associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT hsushihwei associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT huangshuhua associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT leechenchang associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT changwenneng associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT luichunchung associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease
AT lienchiayi associationsofbcl2rs956572genotypegroupsinthestructuralcovariancenetworkinearlystagealzheimersdisease